The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Online Program Home
Abstract Details
|
Activity Number:
|
572
|
|
Type:
|
Contributed
|
|
Date/Time:
|
Wednesday, August 1, 2012 : 2:00 PM to 3:50 PM
|
|
Sponsor:
|
Biopharmaceutical Section
|
| Abstract - #306301 |
|
Title:
|
Islet Cell Transplantation in Type 1 Diabetes: An Analysis of Clinical Outcomes in Data from Collaborative Islet Transplant Registry (CITR)
|
|
Author(s):
|
Jawahar Tiwari*+ and Bruce Schneider and Franca Barton and Steven A Anderson
|
|
Companies:
|
FDA/CBER and FDA/CBER and EMMES Corporation and FDA/CBER
|
|
Address:
|
1401 Rockville Pike, Rockville, MD, 20852, United States
|
|
Keywords:
|
Islet cell transplant ;
Type 1 diabetes ;
CITR ;
study design ;
endpoint ;
sample size
|
|
Abstract:
|
Allogeneic pancreatic islet cell transplantation is regulated as an experimental therapy by the Food and Drug Administration. We have analyzed four clinical and laboratory outcomes measured on 340 subjects who have received one, two, or three transplants. At one year, 59% (95% CI: 52, 64) of the subjects maintained HbA1c value at < 6.5 and were free of severe hypoglycemic episodes. The Kaplan-Meier survival analysis showed that 69%, 54%, and 44% of these one-year responders maintained this composite endpoint at two, three and four years, respectively. These and other outcome results can be very useful in developing study designs, sample size estimates, and analytical plans for future pivotal trials of islet cell transplantation.
|
The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.
Back to the full JSM 2012 program
|
2012 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.